Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2026-02-28 @ 3:30 AM
Study NCT ID:
NCT04990466
Status:
WITHDRAWN
Last Update Posted:
2024-01-19
First Post:
2021-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.
Sponsor:
NeuroRx, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-03
First Submit QC Date:
None
Study First Post Date:
2021-08-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-17
Last Update Post Date:
2024-01-19
Last Update Post Date Type:
ACTUAL